OncoDiag

Private

FranceHealthcare & Life Scienceshttps://www.oncodiag.fr/

Last Round

Follow-on

Feb 5, 2025

Total Funding Raised

$4.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OncoDiag is a genomics company that develops non-invasive diagnostic tests for the early detection and monitoring of bladder, colorectal, and prostate cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

cancer diagnosticsin-vitro diagnosticsliquid biopsynon-invasive diagnosticsmolecular diagnosticsdiagnostic test kitsIVDbladder cancer surveillanceearly cancer detectionepigenetic analysiscancer monitoringbiomarker analysisqPCRprostate cancer testcolorectal cancer testcystoscopy alternative

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoDiag Comps

Public and private peers based on sector, stage, and business model.

OncoDiag comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoDiag Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Follow-on	Feb 5, 2025
Series A	Mar 15, 2021

View all Funding Rounds

OncoDiag Investors

Notable investors and investment history

OncoDiag investors
Investor	Rounds
Les Business Angels des Grandes Écoles	Seed
Normandie Participations	Series A
Paris Business Angels	Follow-on, Series A
Les Business Angels des Grandes Ecoles	Follow-on, Series A
Angels Santé	Follow-on, Seed, Series A
Normandie Participations	Follow-on, Series A
Bpifrance	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 17, 2026
Monthly visitors grew 70% MoM, reaching 1.5K.
May 4, 2025
Monthly visitors grew 136% MoM.

View all signals

OncoDiag Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

OncoDiag Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoDiag's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrance

Employee Range7

Year Founded2013

Last FundingFeb 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.